Japan: Takeda wins shareholder approval for US$59B Shire acquisition

Japan: Takeda wins shareholder approval for US$59B Shire acquisition

Takeda Pharmaceutical has won shareholder approval to finance its £46 billion (US$58.6 billion) purchase of Shire, paving the way for Japan’s largest corporate takeover and the creation of a global drugmaker with combined revenues of US$32 billion. The vote on Wednesday, December 5, caps months of aggressive campaigning by Christophe Weber, Takeda’s CEO, to fend […]

EU: Commission approves acquisition of Shire by Takeda, subject to conditions

EU: Commission approves acquisition of Shire by Takeda, subject to conditions

The European Commission has approved under the EU Merger Regulation the acquisition of Shire by Takeda Pharmaceutical Company. The decision is conditional on the divestment of a biologic treatment product under development by Shire to treat inflammatory bowel disease. Commissioner Margrethe Vestager, responsible for competition policy, said: “There are many diseases with only a limited […]

EU: Takeda considers selling experimental drug to win EU approval

EU: Takeda considers selling experimental drug to win EU approval

Pharmaceutical company Takeda is talking with the European Commission about selling an experimental inflammatory bowel disease drug to help close its US$62 billion takeover of Shire. In a statement released Friday, October 26, Takeda stated that it has been in discussions with the EC about divesting SHP647, which is in the final stages of experimental […]

EU: EC sets date for decision on Takeda’s Shire acquisition

EU: EC sets date for decision on Takeda’s Shire acquisition

On Friday, September 28, the European Commission announced that it has set a deadline of November 6 for its decision on Japanese pharmaceutical company Takeda’s US$62 billion takeover of UK Shire. The proposed deal has already received unconditional approval from the US, Brazil, and China. The EU may approve the deal as-is, with conditions, or […]

US: FTC clears Takeda’s proposed US$62b Shire takeover

US: FTC clears Takeda’s proposed US$62b Shire takeover

Takeda Pharmaceutical has received US regulatory approval for its US$62 billion takeover of Irish drugmaker Shire, clearing a “significant” hurdle to completing Japan’s largest-ever outbound acquisition, reported Bloomberg. The purchase remains subject to a number of conditions, the Japanese company announced in a statement Tuesday, July 10, including other regulatory clearances and approval by shareholders […]